POSTN and breast carcinoma: Kharaishvili et al. [10] performed immunohistochemical study of CTHRC1 in breast cancer with parallel analysis of periostin and versican and found that combined evaluation of stromal expression of CTHRC1 and periostin could serve as a potential marker for breast cancer bone metastasis prediction.